Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wall

Showing results (421-430 of 841) with videos related to

Pageof 85
Sort By:
Animal Biotechnology|January 23, 2009
Enhanced host immune recognition of mastitis causing Escherchia coli in CD-14 transgenic miceR Wall, A Powell, E Sohn, et al.
BMC Nephrology|September 19, 2012
Association of pre-transplant statin use with delayed graft function in kidney transplant recipientsJanske Reiling, David W Johnson, Peter S Kruger, et al.
Thyroid : Official Journal of the American Thyroid Association|April 16, 2002
T-cell-mediated immunity in thyroid-associated ophthalmopathyTomasz Bednarczuk, Yuji Hiromatsu, Yoichi Inoue, et al.
Journal of Endocrinological Investigation|January 1, 1994
Two dimensional gel electrophoresis identifies minor differences in immunologically cross-reactive 64 KDa autoantigens in the thyroid and eye muscleA Boucher, N Bernard, A Miller, et al.
International Journal of Molecular Medicine|January 20, 2000
Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, RehN R Wall, R M Mohammad, K B Reddy, et al.
Journal of Drug Targeting|January 5, 2002
Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell lineN R Wall, F W Beck, A M Al-Katib, et al.
The Journal of Clinical Investigation|October 3, 2001
Cancer gene therapy using a survivin mutant adenovirusM Mesri, N R Wall, J Li, et al.
Cancer Cell|August 2, 2002
A p34(cdc2) survival checkpoint in cancerDaniel S O'Connor, Nathan R Wall, Andrew C G Porter, et al.
Orthopedics|August 2, 2001
Safety of a clinical surveillance protocol with 3- and 6-week warfarin prophylaxis after total joint arthroplastyW M Goldstein, M L Jimenez, D S Bailie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft modelR M Mohammad, N R Wall, J A Dutcher, et al.
Pageof 85

Showing results (421-430 of 841) with videos related to

Sort By:
Pageof 85
Animal Biotechnology|January 23, 2009
Enhanced host immune recognition of mastitis causing Escherchia coli in CD-14 transgenic miceR Wall, A Powell, E Sohn, et al.
BMC Nephrology|September 19, 2012
Association of pre-transplant statin use with delayed graft function in kidney transplant recipientsJanske Reiling, David W Johnson, Peter S Kruger, et al.
Thyroid : Official Journal of the American Thyroid Association|April 16, 2002
T-cell-mediated immunity in thyroid-associated ophthalmopathyTomasz Bednarczuk, Yuji Hiromatsu, Yoichi Inoue, et al.
Journal of Endocrinological Investigation|January 1, 1994
Two dimensional gel electrophoresis identifies minor differences in immunologically cross-reactive 64 KDa autoantigens in the thyroid and eye muscleA Boucher, N Bernard, A Miller, et al.
International Journal of Molecular Medicine|January 20, 2000
Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, RehN R Wall, R M Mohammad, K B Reddy, et al.
Journal of Drug Targeting|January 5, 2002
Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell lineN R Wall, F W Beck, A M Al-Katib, et al.
The Journal of Clinical Investigation|October 3, 2001
Cancer gene therapy using a survivin mutant adenovirusM Mesri, N R Wall, J Li, et al.
Cancer Cell|August 2, 2002
A p34(cdc2) survival checkpoint in cancerDaniel S O'Connor, Nathan R Wall, Andrew C G Porter, et al.
Orthopedics|August 2, 2001
Safety of a clinical surveillance protocol with 3- and 6-week warfarin prophylaxis after total joint arthroplastyW M Goldstein, M L Jimenez, D S Bailie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft modelR M Mohammad, N R Wall, J A Dutcher, et al.
Pageof 85